SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS - Draft Registration Statement:
SEC Accession No. 0001571049-14-000679
Filing Date
2014-03-04
Accepted
2014-03-04 16:41:22
Documents
16

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 3686055
2 filename2.htm EX-3.1 9217
3 filename3.htm EX-3.2 69154
4 filename4.htm EX-4.3 24631
5 filename5.htm EX-10.1 50095
6 filename6.htm EX-10.2 15213
7 filename7.htm EX-10.10 24837
8 filename8.htm EX-10.11 28026
9 filename9.htm EX-10.12 27588
10 filename10.htm EX-10.13 27011
11 filename11.htm EX-10.14 273094
12 filename12.htm EX-10.15 374571
13 filename13.htm EX-10.19 34542
14 GRAPHIC chart.jpg GRAPHIC 268542
15 GRAPHIC logo_angion.jpg GRAPHIC 61918
16 GRAPHIC t1400285_table1.jpg GRAPHIC 81793
  Complete submission text file 0001571049-14-000679.txt   5213468
Mailing Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553
Business Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553 (516) 326-1200
Angion Biomedica Corp. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-00507 | Film No.: 14665429
SIC: 2834 Pharmaceutical Preparations